TP53 and cancer: Although associations between polyploidy and genome evolution with TP53 mutation have been noted previously18,48,49, lineage tracing of pancreas cancer evolution from premalignancy through frank cancer development suggests that genome doubling neither precedes p53 inactivation nor is the first selected event after p53 loss.